Changing Lives with Protein Restoration
DiaMedica Therapeutics is committed to improving the lives of people suffering serious diseases with initial focus on acute ischemic stroke (AIS) and chronic kidney disease (CKD). We have manufactured, patented and in licensed technology for the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, for the treatment of AIS and CKD.
More About DiaMedica